Form 4 for BMEA Biomea Fusion, Inc.
Accepted 2025-08-13 00:00:00 ET · period of report 2025-01-28 · accession 0000950170-25-108041 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2025-08-13 | 2025-01-31 | BMEA | Erdtmann Rainer M | See Remarks, Dir | G - Gift | $0.00 | +30.0K | 19.4K | New | $0 |
| DM | 2025-08-13 | 2025-01-28+ | BMEA | Erdtmann Rainer M | See Remarks, Dir | G - Gift | $0.00 | -70.0K | 643.0K | -10% | $0 |
| D | 2025-08-13 | 2025-08-11 | BMEA | Erdtmann Rainer M | See Remarks, Dir | A - Grant | $0.00 | +1.25M | 1.25M | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-31 | G | A | 10,000 | $0.00 | 20,000 | I | — | — | |
| 2 | Common | Common Stock | 2025-01-31 | G | A | 10,000 | $0.00 | 20,000 | I | — | — | |
| 3 | Common | Common Stock | 2025-01-28 | G | D | 40,000 | $0.00 | 673,027 | D By daughter | — | — | |
| 4 | Common | Common Stock | 2025-01-31 | G | D | 10,000 | $0.00 | 663,027 | D By son | — | — | |
| 5 | Common | Common Stock | 2025-01-31 | G | A | 10,000 | $0.00 | 19,400 | I By daughter | — | — | |
| 6 | Common | Common Stock | 2025-01-31 | G | D | 10,000 | $0.00 | 653,027 | D | — | — | |
| 7 | Common | Common Stock | 2025-01-31 | G | D | 10,000 | $0.00 | 643,027 | D | — | — | |
| 8 | Derivative | Stock Option (Right to Buy) | 2025-08-11 | A | A | 1,246,989 | $0.00 | 1,246,989 | D | $1.53 · — to 2035-08-10 | 1,246,989 Common Stock | (F5) The option shall vest and become exercisable in 16 substantially equal quarterly installments after August 8, 2025, such that the award will be fully vested and exercisable on August 8, 2029, subject to the Reporting Person's continued service to the Issuer through each vesting date. |